Background: Breast cancer can present as non-mass lesions (NMLs) on ultrasound. However, knowledge of and understanding about NMLs are scarce. Purpose: To retrospectively investigate the final outcomes of sonographic breast NMLs and determine the clinical and radiologic variables associated with malignancy Material and Methods: In our radiologic database of breast ultrasound examinations between 2011 and 2014, we found 119 women with 121 NMLs with available histopathologic or sonographic follow-up (over 2 years) data. We collected the clinical variables (patient's age, symptoms, and mammographic density) and histopathologic data as well as radiologic variables (mammographic and ultrasound findings) after retrospective review by two radiologists, the authors of the current paper, in consensus. We classified the ultrasound findings according to distribution (focal, linear or segmental, and regional) and associated features (calcification, architectural distortion, and ductal changes) and analyzed the associations between variables and malignancy using the t test and 2 test. Results: Of the 121 NMLs, 88 (72.7%) were benign and 33 (27.3%) were malignant. Ductal carcinoma in situ (DCIS) (17/33, 51.5%) and invasive ductal cancer with or without DCIS (13/33, 39.4%) comprised the main malignancies, and malignancy was significantly associated with palpability (P ¼ 0.000). Mammographic findings and sonographic distribution and associated features were significantly different between benign and malignant lesions (P ¼ 0.000, P ¼ 0.004, and P ¼ 0.001, respectively). Malignant lesions showed more frequent calcifications combined with asymmetry (P ¼ 0.000) on mammography and linear-segmental distributions (P ¼ 0.001) and associated calcifications (P ¼ 0.019) or architectural distortions (P ¼ 0.015) on ultrasound. Conclusion: Breast NMLs on ultrasound showed high risk of malignancy. Symptoms and mammographic and ultrasound findings can be possible predictors of malignancy in NMLs.
Introduction
Breast ultrasound (US) has been well established as a valuable modality in differentiating benign from malignant lesions in many well-designed reader studies (1, 2) . However, the lesions included in these studies were nearly all breast masses, and there has been no interest in non-mass breast lesions in breast US research. With two-dimensional breast US, a mass can be defined as a space-occupying lesion seen in two different planes, but if it cannot be characterized as a mass because of lack of a conspicuous margin or shape, it should be reported as a non-mass lesion (NML). It has been described as synonymous terms such as non-mass like lesion, non-mass lesion, non-mass image-forming lesion, ductal changes, duct-like structures, and focal shadowing (3) (4) (5) (6) (7) . The multiplicity of names reflects an underlying uncertainty as to the true nature of sonographic NMLs. Uematsu et al. (3) first introduced nonmass-like lesions detected on breast US in their review article and classified them as ductal hypoechoic areas and non-ductal hypoechoic areas. In addition, according to a few prior articles (4) (5) (6) (7) , the incidence of such lesions was 5.3% on screening or diagnostic breast US examinations, and moreover, these followed a wide pathologic spectrum from benign lesions such as fibrocystic changes or stromal fibrosis to malignancy ones such as ductal carcinoma in situ (DCIS) or invasive cancer that showed high association with malignancy (16-35%). However, knowledge of and understanding about NMLs are still scarce, and there have been few published reports regarding NMLs (3) (4) (5) (6) (7) . Therefore, our study aimed to investigate the final outcomes of non-mass breast lesions detected on US and determine their clinical and radiologic variables to differentiate between benign and malignant lesions.
Material and Methods
The institutional review board approved this study, and informed consent was waived.
Study cohort
Through our radiologic records of all breast US examinations from January 2011 to December 2014, we identified 125 consecutive patients with 129 lesions classified as breast NMLs. Eight (6.2%) of the 129 lesions were excluded because histopathologic results or sonographic follow-up over 2 years were not available. The remaining 121 NMLs in 119 patients comprised the dataset of our study ( Fig. 1 ). Two patients had two lesions and two had a personal history of breast cancer.
The mean age of the patients was 46.5 years (age range, 21-69 years). Thirty-nine (32.2%) of the total of 121 NMLs were associated with symptoms, including palpability (n ¼ 28) and nipple discharge (n ¼ 11). Eighty-two (67.8%) lesions were detected in asymptomatic patients. The mean size of the lesions was 25.3 mm (range, 6-63 mm).
Mammography
Mammography was available for 95 (78.5%) patients with 97 lesions during the US examinations. Four mammographic studies in four patients had been performed in outside hospitals. Omission of mammography in 24 (21.5%) patients was due to their youth (aged less than 40 years). The mammographic tissue density of each patient was collected from the reported data, and the authors of the study, two radiologists with 10-11 years of experience in breast imaging, reviewed the mammographic findings for the areas that corresponded with the NMLs until consensus. We categorized breast tissue density as almost fatty, scattered fibroglandular, heterogeneously dense, or extremely dense according to the Breast Imaging Reporting and Data System (BI-RADS) (8) , and categorized the findings as negative, mass, calcifications ( Fig. 2) , asymmetry ( Fig. 3 ), or architectural distortion.
Ultrasound
All breast US examinations were hand-held sonography scans and were performed by one of three radiologists who had practiced as faculty in an academic breast imaging section over 5-10 years, and all included bilateral whole breasts and axillae with the patient in the supine position with the ipsilateral arm raised. Aixploler (Supersonic Imagine, Aix-en-provence, France), IU 22 (Philips, Medical Systems, Bothell, WA, USA) or HDI 5000 (Philips Advanced Technology Laboratories, Bothell, WA, USA) US systems were used with an 8-13 MHz linear array transducer. The radiologist who performed the US was informed of all clinical and mammographic findings. All lesions were assessed in both radial and anti-radial scanning planes. With real-time scanning, if the lesion was visible on two orthogonal planes but could not be characterized as a distinct mass because of lack of a conspicuous margin or shape, we considered it an NML.
For each NML, we retrospectively reviewed its distribution and associated sonographic features. Before the study, we had discussed the concise definitions of the descriptors and come to consensus about them using detailed documents. For distribution, we classified the NMLs as focal, linear-segmental, or regional pattern. A focal distribution was defined as a small and confined area. A linear-segmental distribution (Fig. 2 ) was defined as a longitudinal or a triangular area that arrayed in a line or along the branches involving one or more ducts. A regional distribution ( Fig. 3 ) was defined as a large geographic area of tissue that did not conform to a ductal or segmental distribution. For associated features, we sorted the NMLs into the categories of calcifications, architectural distortion, or abnormal Axial first contrast-enhanced subtraction MR image (d) shows homogeneous, segmental non-mass enhancement (arrows) in the corresponding area in the right breast. Sonographically guided core biopsy was performed and the specimen radiograph. Core biopsy and surgery confirmed the lesion to be DCIS (high grade, comedo type, without microinvasion). ductal changes. We recognized associated calcifications as echogenic foci or echogenic flecks with or without shadowing that were embedded in the NML, near the outside of the NML, or in a duct or ducts. We considered architectural distortion to be compression of the tissue around the NML, obliteration of the tissue planes by an infiltrating lesion, straightening or thickening of Cooper ligaments, aberrations of ductal patterns, or an echogenic rim. Abnormal ductal changes meant the cystic or cylindrical dilatation of a duct or ducts involving irregularities in caliber and/or arborization, extension of ducts or the presence of an intra-ductal mass, thrombus, or detritus.
Biopsy and surgery
US-guided biopsies were performed with high resolution US units with an 8-13 MHz linear array transducer using a freehand technique. Tissue specimens were obtained with a 14-gauge automated needle (Pro-Mag 2.2, Manan Medical Products, Northbrook, IL, USA) and a 14-gauge Tru-Cut needle with a 22 mm throw (SACN TM Biopsy Needle, Medical Device Technologies, Gainesville, FL, USA) or vacuumassisted needle (Mammotome; Ethicon Endo-Surgery, Cincinnati, OH, USA) by one of the radiologists with 5-10 years of experience in breast imaging and biopsy. US-guided 14-gauge core biopsy was performed for 101 lesions and US-guided vacuum-assisted needle core biopsy was performed for eight lesions. Forty lesions were surgically excised, and in cases of non-palpable lesions, US-guided preoperative localization was done with a 21-gauge Kopan needle.
Statistical analysis
We conducted the statistical analyses using Student's t test, 2 test, or Fisher's exact test to evaluate whether clinical (age, symptom, and mammographic density) and radiologic (mammographic abnormality, US features) variables were associated with malignancy. We used the final histopathologic results as a standard to assess malignancy and categorized the lesions as benign or malignant lesions. High-risk lesions were considered benign for statistical analysis. P value of <0.05 was considered statistically significant. All statistical analyses were conducted using software (SPSS, version 22.0: SPSS Inc, Chicago, IL, USA).
Results

Final outcomes
Of the 121 lesions, we obtained tissue diagnoses for 115 (95%), and sonographic follow-up over 2 years was performed for six (5%) lesions. For 40 lesions, including 39 that were confirmed histopathologically by core biopsy, surgery was performed within 0-5 months because of the presence of malignancy (n ¼ 33), core biopsy results of imaging-histologic discordance (n ¼ 2), high-risk pathologic findings including atypical ductal hyperplasia (n ¼ 2), atypical lobular hyperplasia (n ¼ 1), and pleomorphic lobular carcinoma in situ (n ¼ 1), or physician's decision (n ¼ 1).
The 
Clinical variables
The clinical findings between the benign and malignant NMLs are shown in Table 1 . Patients with malignant NMLs had more frequent symptoms compared with those with benign NMLs (P ¼ 0.000). Among the 88 benign lesions, 19 (21.6%) had associated symptoms. The most common symptom was nipple discharge (11/88, 12.5%), followed by palpability (8/88, 9.1%) ( Fig. 3 ). Whereas 20 (60.6%) of the 33 malignant lesions had symptoms, palpability was the only symptom. Palpability was more frequent in patients with malignant NMLs than in those with benign NMLs (P ¼ 0.000). However, other clinical findings, such as age and mammographic density, were not significantly different between the benign and malignant lesions. Table 2 summarizes the radiologic findings between the benign and malignant NMLs. Malignant NMLs were more associated with mammographic abnormalities than were benign NMLs (27/32, 84.4% versus 25/63, 39.7%, P ¼ 0.000). Among the 32 malignant lesions, the most common mammographic abnormalities were calcification combined with asymmetry (12/32, 37.5%), followed by calcification (9/32, 28.1%) (Fig. 2) . Calcification combined with asymmetry was more frequent in malignant than in benign lesions (P ¼ 0.000), but calcification alone showed no significant difference. Four (30.8%) of 13 mammographic calcifications with benign NMLs were classified into BI-RADS category 4A, and the remaining nine were in category 3. Meanwhile, all 21 calcifications in malignant NMLs were classified into BI-RADS categories 4 or 5.
Radiologic variables
The US examinations showed significant differences in the distribution between the benign and malignant lesions (P ¼ 0.004). Fifteen (45.5%) of the 33 malignant NMLs showed linear or segmental distributions (Fig.  2) , followed by focal (11/33. 33.3%) and regional (7/33, 21.2%) ( Fig. 3) , whereas among the 88 benign lesions, focal distribution was noted in 53 (60.2%), regional distribution in 20 (22.7%), and linear or segmental distribution in 15 (17%). Linear or segmental distribution was more common in malignant than in benign lesions (P ¼ 0.001) (Fig. 2) . US associated features were more frequently seen in malignancy lesions (21/33, 63.6% versus 20/88, 22.7%, P ¼ 0.001). Among the associated features, calcifications were the most commonly seen in both benign and malignant lesions but showed a significant difference between the two (9/88, 10.2% versus 9/33, 27.3%, P ¼ 0.019) (Fig. 2) . Architectural distortion was also a more frequent associated feature in malignant than in benign lesions on US (6/33, 18.2% versus 4/88, 4.5%, P ¼ 0.015).
Discussion
The histopathological results revealed in this study corresponded to those of previous articles (3-7) and many of NMLs on breast US were identified as DCIS or DCIS with minimal IDC (10.2-20.7%) or 24 (32%) of 77 cases of DCIS were non-mass image forming type (4) (5) (6) (7) . In other research on the sonographic features of DCIS (9,10), 26 (11%) of 231 DCIS or seven (19%) of 36 non-calcified DCIS showed as NMLs and asymptomatic or low-grade DCIS was more associated with NMLs than masses.
With regards to the US findings for the NMLs, because there is no standardized method for analysis, prior articles each used different methods for analysis (3) (4) (5) (6) 11) . In 2004, the Japanese Association of Breast and Thyroid Sonology systemically organized and classified NMLs. Their criteria included abnormal ductal changes, a multiple vesicular pattern, hypoechoic areas in the breast tissue, and architectural distortion (11) . Morishma et al. categorized ultrasonic non-mass image forming breast cancers into four types: a homogeneous pattern, a ductal pattern, a mottled pattern, and a geographic pattern, and concluded that the geographic pattern often contained invasive components (4) . In recent study by Ko et al. (5) , US features of 120 benign and 44 malignant NMLs were categorized into four types according to orientation, calcification, architectural distortion, and posterior acoustic shadowing, which was useful for clarifying the indication for biopsy of the NMLs. Meanwhile, Kim et al. (6) classified US features of 156 benign and 30 malignant NMLs into according to type, distribution, color flow, and positive calcifications. In their study, malignant lesions more frequently had mottled and geographic patterns, regional distribution, visible calcification, and a greater amount of color Doppler signals than benign lesions (6) . As mentioned above, US feature description of NMLs has not been standardized, and, moreover, some of the previous US feature analyses were complicated and irreproducible, resulting in inter-observer disagreement. To overcome this limitation, this study had two radiologists who simply analyzed US findings to consensus. We classified the NMLs according to distribution and associated features. Linear or segmental distribution (P ¼ 0.001) and associated calcification (P ¼ 0.019) or architectural distortion (P ¼ 0.015) were predictable for malignancy. Some of our results correlated with those of the prior studies (3) (4) (5) (6) . For instance, linear-segmental distribution might be similar to the ductal hypoechoic area in the study by Uematzu et al. (3) and the ductal NML pattern in the study of Ko et al. (5) . Both of these groups of authors defined a ductal hypoechoic area or a ductal NML pattern as a lesion with the parallel orientation of multiple duct-like structures (3, 5) . The definition was similar to our criteria for linear or segmental distribution. According to both sets of authors, a ductal hypoechoic area was an indication for biopsy and positive predictive value was high when associated calcifications were present regardless of ductal or non-ductal patterns (5) . Compared with that linear or segmental non-mass enhancement on magnetic resonance imaging (MRI) was more likely to indicate malignancy, particularly DCIS (12), it is convincing that linear-segmental distribution is more associated with malignant NMLs on US. In our 33 malignant lesions, 15 (45.5%) had linear or segmental distribution and, among these, 10 (66.7%) were DCIS (90%, 9/10) or DCIS with micro-invasive ductal cancer (10%, 1/10). Further extended study would be needed to compare the NML findings on US with those on MRI, in order to verify the exact feature.
US associated calcification was a predictive factor for malignancy both in most prior studies and in this one (4) (5) (6) . Nine (10.2%) of 88 benign and nine (27.3%) of 33 malignant lesions showed calcifications on US with a statistically significant difference (P ¼ 0.019). Calcifications have been poorly characterized with sonography, but those associated with malignant tumors were more likely to be seen sonographically because most malignant calcifications occurred within hypoechoic breast masses as opposed to within echogenic breast parenchyma in previous studies (13) (14) (15) , and we also observed this with NMLs. Additionally, US associated architectural distortion was also more frequent in malignant (6/33, 18.2%) than benign (4/88, 4.5%) NMLs.
For the clinical findings, palpability predicted malignancy with the frequency of 20 (60.6%) of 33 malignant lesions and eight (9.1%) of 88 benign ones in our study. Kim et al. also reported that palpability was significantly associated with malignancy showing higher frequency (50%) in 30 malignant lesions compared with 2.6% (4/156) in benign ones (6) .
According to Ko et al. (5) , asymmetry combined with calcification had no statistical difference between benign and malignancy lesions, and only the mammographic finding of suspected malignancy had a higher probability of malignancy. However, in our study, mammographic abnormality was one of the predictive variables for malignancy. Calcification combined with asymmetry was significantly more visible in malignant (37.5%, 12/32) than in benign (6.3%, 4/63) NMLs. Among our 27 cases with mammographic findings that were suspicious for malignancy, there were 20 (62.5%) malignancies and seven (11.1%) benign lesions. Four (30.8%) of the 13 benign NMLs and all 21 of the malignant NMLs were classified as BI-RADS categories 4 or 5.
There were limitations to our study. First, interobserver variability and irreproducibility are wellknown limitations of sonography. To reduce these limitations, two experienced breast imaging specialists discussed the concise definitions of the descriptors and reached consensus on them using detailed documents during the retrospective analysis of the US findings. However, there is a need for an exact and concrete definition of NMLs and future extended studies including inter-observer variability will allow for their uniform standardization. Second, this study was performed at a single site institution and included only a small number of subjects. As a result, some variable subgroups were poorly populated. Additional research is needed at multiple institutions with larger numbers of subjects.
In conclusion, breast NMLs on US showed high risk of malignancy and DCIS was the main malignant pathology. NMLs have to be managed according to the clinical, mammographic, and US findings. Palpability, mammographic calcifications combined with asymmetry, US linear-segmental distribution, and US associated calcifications or architectural distortion were more common in malignant than in benign NMLs.
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